Saturday 17 October 2026 Export BCRX’s income statement to Excel — free account

BioCryst Pharmaceuticals, Inc.

BCRX Healthcare Drug Manufacturers Specialty & Generic

BioCryst Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $874.8 million, up 94.1% from fiscal 2024. In the quarter to June 2026, revenue grew 33.6%, EPS grew 1,450.0%, free cash flow grew 153.2% and total debt rose 15.2%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

7.79 0.23 −2.87%

Follow BCRX

Alert me

Market cap: $2.1B
P/E: 0.0×
Fwd P/E: −3.5×
Dividend yield: —
F-score: 7/9
Altman Z: 1.83
Beneish M: −2.27
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	6.24	0.00	0.00
P/S ratio Full definition →		2.66	1.87	2.60	2.71
P/FCF ratio Full definition →		33.33	4.74	7.42	6.81
P/Operating CF Full definition →		38.32	5.61	(37.32)	24.39
P/B ratio Full definition →		0.00	0.00	0.00	0.00
Price to Tangible BV Full definition →		0.00	0.00	0.00	0.00
EV/Sales Full definition →		3.43	2.11	3.30	3.22
EV/EBITDA Full definition →		28.78	5.45	0.00	0.00
EV/Operating CF Full definition →		40.93	5.31	9.35	8.06
EV/FCF Full definition →		42.94	5.34	9.41	8.11
Quick Ratio Full definition →		1.60	1.95	1.78	2.22
Current Ratio Full definition →		1.87	2.06	1.91	2.32
Net Debt/EBITDA Full definition →		16.28	0.79	(0.89)	4.92
Debt/Assets Full definition →		150.73%	93.53%	184.94%	150.47%
Debt/Equity Full definition →		(1.73)	(4.04)	(1.55)	(1.85)
Asset Turnover Full definition →		1.28	1.74	1.87	1.85
Operating CF/Net income Full definition →		3.23	1.19	0.09	1.33
Capex/Depreciation Full definition →		0.98	0.36	(0.28)	(0.70)
Interest Coverage Full definition →		1.51	18.42	(35.47)	4.54
Research and Development Expense of Revenue Full definition →		27.98%	10.05%	38.56%	23.81%
Selling, General and Administrative Expense of Revenue Full definition →		52.08%	23.56%	60.45%	29.31%
Intangible Assets out of Total Assets Full definition →		0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		11.67%	5.85%	10.25%	6.73%
Graham Net Nets Full definition →		(0.30)	(0.14)	(0.28)	(0.21)
Graham Number Full definition →		1.44	0.00	9.43	7.61
Earnings Yield Full definition →		(0.66%)	16.03%	(18.17%)	(14.40%)
Free Cash Flow Yield Full definition →		3.00%	21.10%	13.48%	14.69%
Revenue per Share Full definition →		0.76	1.94	0.65	0.86
Operating CF per Share Full definition →		0.20	1.39	(0.26)	0.41
Capex per Share Full definition →		(0.01)	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		0.19	1.39	(0.26)	0.41
Cash per Share Full definition →		1.02	1.31	0.99	1.39
Shareholders Equity per Share Full definition →		(1.85)	(0.57)	(2.29)	(1.79)
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		(1.85)	(0.57)	(2.29)	(1.79)
Free Cash Flow Full definition →		40.28	291.71	(62.19)	104.13
Working Capital Full definition →		165.45	208.28	178.23	275.84
Capital Expenditures Full definition →		(1.34)	(0.25)	(0.40)	(0.21)
Net Current Asset Value Full definition →		(478.63)	(228.96)	(645.27)	(527.46)
EV/EBIT Full definition →		27.00	5.41	0.00	0.00
Capex to Sales Full definition →		0.01	0.00	0.00	0.00
Price to Operating Income Full definition →		20.96	4.80	0.00	0.00
Other line items
Average Receivables Full definition →		81.89	92.94	101.33	100.97
Average Payables Full definition →		9.52	13.74	10.50	10.02
Average Inventory Full definition →		6.40	6.74	6.43	5.55
Average Assets Full definition →		468.84	502.29	472.55	507.52
Average Common Equity Full definition →		(428.23)	(297.54)	(502.88)	(437.94)

Fold the line items

Columns are period end dates

Stockrow Weekly